| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Emerging psychosis in young people - Part 2 - key issues for acute management Fraser R; Berger G; McGorry PAust Fam Physician  2006[May]; 35 (5): 323-7BACKGROUND: To optimise the management of emerging psychotic disorders in young  people, close collaboration between the general practitioner and youth friendly  specialist mental health services is favourable. Ideally, a multidisciplinary  team including individual case management with expertise in early intervention  should treat these patients for the initial 2-5 years. However, only a few areas  across Australia currently provide this type of specialised service. Most GPs  will at some point be faced with the reality of personally managing young  patients with emerging psychotic disorders on their own, sometimes with very  limited support. OBJECTIVE: This article summarises key issues for the optimal  management of emerging psychotic disorders, with a particular focus on the role  of the GP. DISCUSSION: Once an emerging psychotic disorder is confirmed, the  engagement of the young person into therapy is the primary target. Ideally  therapy integrates not only the patient, but also their family, carers and  friends. General practitioners need to inform patients about the nature of the  emerging psychotic illness, manage related comorbidities such as substance abuse,  and initiate antipsychotic medication to avoid any unnecessary delay in  resolution of symptoms. It is important to monitor the patient on a regular basis  even after symptom recovery as up to 80% of cases that cease medication will  relapse within 5 years.|Adolescent[MESH]|Adult[MESH]|Anti-Anxiety Agents/therapeutic use[MESH]|Antidepressive Agents/therapeutic use[MESH]|Antipsychotic Agents/therapeutic use[MESH]|Anxiety/complications/drug therapy[MESH]|Depression/complications/drug therapy[MESH]|Dose-Response Relationship, Drug[MESH]|Family Practice/methods[MESH]|Female[MESH]|Humans[MESH]|Male[MESH]|Patient Care Team[MESH]|Patient Compliance[MESH]|Patient Education as Topic/methods[MESH]|Psychotic Disorders/complications/diagnosis/*therapy[MESH]|Risk Assessment/methods[MESH]|Substance-Related Disorders/complications/therapy[MESH]
 |